Coffee and human health: a focus on the substances of the beverage related to cardiovascular disease
Keywords:
Chlorogenic acids, Coffee, Caffeine, Dyslipidemias, Diterpenes, HypertensionAbstract
Coffee is the most consumed beverage in the Western world, including Brazil. The fact that it is one the most popular beverages and its worldwide consumption and economic importance explain the interest for studies on coffee, from its composition to its effects on human health. In addition to the nutrients, its various components include caffeine, the diterpenes cafestol and kahweol, and chlorogenic acids, with coffee being an important dietary source of these compounds. Many studies have verified the association between its constituents and health, especially caffeine and high blood pressure, cafestol and kahweol and dyslipidemias, and chlorogenic acids and cardiovascular protection from their antioxidant properties. This article aims to succinctly present the
importance and composition of the drink, the physiological mechanisms involved in the increased blood pressure and serum cholesterol attributed to coffee, and selected studies that verified the association between coffee consumption and these cardiovascular diseases.
Downloads
References
Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 2006; 46:101-23.
Hamer M. Coffee and health: explaining conflicting results in hypertension. J Hum Hypertens. 2006; 20:909-12.
Sudano I, Binggeli C, Spieker L, Luscher TF, Ruschitzka F, Noll G, et al. Cardiovascular effects of coffee: is it a risk factor? Prog Cardiovasc Nurs. 2005; 20:65-9.
Lopez-Garcia E, Van Dam RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, et al. Coffee consumption and coronary heart disease in men and women. Circulation. 2006; 113:2045-53.
Bonita JF, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res. 2007; 55: 187-98.
Dórea JG, Costa THM. Is coffee a functional food? Br J Nutr. 2005; 93:773-82.
Van Dam RM, Willet WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care. 2006; 29:398-403.
Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus. Arch Intern Med. 2006; 166:1311-16.
Van Dam RM. Coffee and type 2 diabetes: from beans to beta-cells. Nutr Metabol Cardiovasc Dis. 2006; 16:69-77.
Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes and weight control. Am J Clin Nutr. 2006; 84:682-93.
Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005; 129:1928-36.
Nakasato M, Giorgi DMA, Isosaki M. Mitos e verdades sobre o café e doenças do coração. Rev Soc Cardiol Estado de São Paulo. 2001; 11(6):13-20.
Monteiro MC, Trugo LC. Determinação de compostos bioativos em amostras comerciais de café torrado. Quim Nova. 2005; 28(4):637-41.
Moreira RFA, Trugo LC, De Maria CAB. Componentes voláteis do café torrado. Parte II: compostos alifáticos, alicíclicos e aromáticos. Quim Nova. 2000; 23(2):195-203.
Masten S, Tice R. Cafestol and kahweol. Review of toxicological literature. Research Triangle Park (NC): ILS; 1999 p.2-39.
Lancaster T, Muir J, Silagy C. The effects of coffee on serum lipids and blood pressure in a UK population. J Royal Soc Medicine. 1994; 87:506-7.
Dusseldorp MV, Katan BM, Van Vliet T, Demacker PNM, Stalenhoef AFH. Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb. 1991; 11:586-93.
Zock PL, Katan MB, Merkus MP, Dusseldorp MV, Harryan JL. Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet. 1990; 335: 1235-37.
Costa RP, Izar MCO, Elias MC, Ihara SSM, Santos AO, Pinto LESA, et al. Moderate comsumption of drip paper-filtered or boiled and cotton-filtered coffee does not affect lipid profile, and improves lipid peroxidation in patients with primary hypercholesterolemia. Int J Atheroscler. 2006; 1(2): 149-55.
Brasil. Associação Brasileira da Indústria do Café (ABIC). [acesso 2008 jan 17]. Disponível em: <http://www.abic.com.br/>.
De Maria CA, Moreira RFA, Trugo LC. Componentes voláteis do café torrado. Parte I: compostos heterocíclicos. Quim Nova. 1999; 22(2):209.
Fernandes SM, Pinto NAVD, Thé PMP, Pereira RGFA, Carvalho VD. Teores de polifenóis, ácido clorogênico, cafeína e proteína em café torrado. Rev Bras de Agrociência. 2001; 7(3):197-99.
Núcleo de Estudos e Pesquisa em Alimentação. Tabela Brasileira de Composição de Alimentos (TACO); versão II. Campinas: Flamboyant; 2006.
Jack E, James E. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosom Med. 2004; 66: 63-71.
Birkett NJ, Logan AG. Caffeine-containing beverages and the prevalence of hypertension. J Hypertens. 1988; 6(4):S620-22.
Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol. 1989; 42:877-84.
Jee SH, He J, Whelton PK, Suh L, Klag M. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials.
Hypertension. 1999; 33:647-52.
Hartley TR, Sung BH, Pincomb GA, Whitsett TL, Wilson MF, Lovallo WR. Hypertension risk status and effect of caffeine on blood pressure. Hypertension. 2000; 36:137-41.
Klag MJ, Wang NY, Meoni LA, Brancati FL, Cooper LA, Liang KY, et al. Coffee intake and risk of hypertension. Arch Int Med. 2002; 162:657-62.
Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a metaanalysis of randomized controlled trials. J Hypertens. 2005; 23:921-8.
Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and risk of hypertension in women. JAMA. 2005; 294(18): 2330-35.
Andersen LF, Jacobs Jr DR, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2006; 83:1039-46.
Uiterwaal CSPM, Verschuren WM, Bueno-deMesquita HB, Ocké M, Geleijnse JM, Boshuizen HC, et al. Coffee intake and incidence of hypertension. Am J Clin Nutr. 2007; 85:718-23.
Urgert R, Katan MB. The cholesterol-rasing factor from coffee beans. Ann Rev Nutr. 1997; 17:305-24.
Jee SH, He J, Appel LJ, Whelton PK, Suh II, Klag MJ. Coffee consumption and serum lipids: a metaanalysis of randomized controlled clinical trials. Am J Epidemiol. 2001; 153(3):353-62.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr. 2003; 133: 3228-32.
Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr. 2004; 134:2381-6.
Hammar N, Andersson T, Aldredsson L, Reuterwall C, Nilsson T, Hallqvist J, et al. SHEEP and the VHEEP study. Association of boiled filtered coffee with incidence of first nonfatal myocardial infarction:the SHEEP and the VHEEP study. J Intern Med. 2003; 253:653-9.
Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J. 2004; 147:999-1004.
Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles X, Campos H. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology. 2006; 17:506-11.
Silletta MG, Marfisi RM, Levantesi G, Boccanelli A, Chieffo C, Fransozi MG, et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction. Circulation. 2007; 116: 2944-51.
Sofi F, Conti AA, Gori AM, Eliana Luisi ML, Casini A, Abbate M, et al. Coffee and consumtion and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2007; 17(3):209-23.
Speer K, Kolling-Speer I. The lipid fraction of the coffee bean. Braz J Plant Physiol. 2006; 18(1):201-16.
Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. F Chem Toxic. 1997; 35:547-54.
De Roos B, Katan MB. Possible mechanisms underlying the cholesterol-raising effect of the coffee diterpene cafestol. Curr Opin Lipidol. 1999; 10:41-5.
Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997, 89:331-40.
Boekschoten MV, Hofman MK, Buytenhek R, Schouten EG, Princen HMG, Katan MB. Coffee oil consumption increases plasma levels of 7α-hydroxy-4-cholesten-3-one in humans. J Nutr. 2005;135(4):785-9.
Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996; 1302: 93-102.
Vasconcelos SML, Silva MAM, Goulart MOF. Pró-antioxidantes e antioxidantes de baixo peso molecular oriundos da dieta: estrutura e função. Nutrire. 2006; 31(3); 95-118.
Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002; 288:2569-78.
Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003; 78(Suppl 1):S544-S51.
Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000; 63:1035-42.
Arabbi PR, Genovese MI, Lajolo FM. Flavonoids in vegetable foods commonly consumed in Brazil and estimated ingestion by the brazilian population. J Agric Food Chem. 2004; 52:1124-31.
Soares SE. Ácidos fenólicos como antioxidantes. Rev Nutr. 2002; 15(1):71-81. doi: 10.1590/S1415-52732002000100008.
Farah A, Donangelo CM. Phenolic compounds in coffee. Braz J Plant Physiol. 2006; 18(1):23-36.
Natella F, Nardini M, Belelli F, Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr. 2007; 86: 604-9.
Silva DCF, Nascimento MA, Moreira AVB. Verificação da presença de compostos fenólicos com propriedades antioxidantes em amostras de café. J Braz Soc Food Nutr. 2007; 32(1):23-40
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fabiana Accioly de LIMA, Antônio Euzébio Goulart SANT’ANA, Terezinha da Rocha ATAÍDE, Cristhiane Maria Bazílio de OMENA, Maria Emília da Silva MENEZES, Sandra Mary Lima VASCONCELOS
This work is licensed under a Creative Commons Attribution 4.0 International License.
